Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Alfacalcidol→

Alfacalcidol Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
41294-56-8
Molecular formula
C27H44O2
Molecular weight
400.6 g/mol
Drug class
Vitamin D analogue (1α-hydroxyvitamin D3)
Mechanism of action
A pro-vitamin D analogue converted rapidly in the liver to 1,25-dihydroxyvitamin D, the active metabolite that regulates calcium and phosphate metabolism and increases intestinal calcium and phosphate absorption.
Indications / reported uses
  • Renal osteodystrophy
  • Hyperparathyroidism with bone disease
  • Hypoparathyroidism
  • Nutritional or malabsorptive rickets and osteomalacia
  • Hypophosphataemic vitamin-D-resistant rickets and osteomalacia

Sources: UK SmPC (eMC)

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Alfacalcidol Environmental Risk Assessment (ERA) (the Alfacalcidol ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.